WebDisclosure WebDisclosure
Basculer en Français
11114 Companies
244627 Keywords
172664 Articles
131840 Press releases
Headlines Articles Press releases Wilmington Eye Remove
  1. Home
  2. Companies
  3. Wilmington Eye
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/28/2024 at 22:35, 2 years 4 months ago

    Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma

    Medical Innovation Ocular Hypertension Wilmington Eye IDose TR Glaucoma Treatment
  • BRIEF

    published on 05/28/2024 at 22:35, 2 years 4 months ago

    Wilmington Eye propose désormais iDose(R) TR comme nouvelle option de traitement pour réduire la pression oculaire chez les patients souffrant d'hypertension oculaire et de glaucome à angle ouvert

    Innovation Médicale IDose TR Oeil De Wilmington Traitement Du Glaucome Hypertension Oculaire
  • PRESS RELEASE

    published on 05/28/2024 at 22:30, 2 years 4 months ago

    Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma

    Wilmington Eye introduces iDose TR for long-term control of elevated eye pressure in glaucoma patients. iDose TR is an FDA approved treatment providing continuous drug therapy inside the eye
    FDA Approved Wilmington Eye IDose TR Glaucoma Treatment Eye Pressure Control
    Logo of Wilmington Eye
Accesswire
  • Published on 10/02/2026 at 00:35, 2 hours 58 minutes ago

    Medicure Announces Grant of Stock Options

  • Published on 10/02/2026 at 00:30, 3 hours 3 minutes ago

    Immutable Holdings Provides Corporate Update

  • Published on 10/01/2026 at 23:05, 4 hours 28 minutes ago

    Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team

  • Published on 10/01/2026 at 22:00, 5 hours 33 minutes ago

    Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos

  • Published on 10/01/2026 at 19:05, 8 hours 28 minutes ago

    PEL 90 Participating Interest Exchange with Chevron

View all ACCESSWIRE
EQS Group
  • Published on 10/02/2026 at 00:01, 3 hours 32 minutes ago

    PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026

  • Published on 10/01/2026 at 23:15, 4 hours 17 minutes ago

    CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

  • Published on 10/01/2026 at 20:45, 6 hours 47 minutes ago

    Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification

  • Published on 10/01/2026 at 20:30, 7 hours 3 minutes ago

    Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow

  • Published on 10/01/2026 at 18:55, 8 hours 37 minutes ago

    Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios

View all EQS
Les Echos
  • Published on 10/01/2026 at 19:00, 8 hours 33 minutes ago

    AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions

  • Published on 10/01/2026 at 19:00, 8 hours 33 minutes ago

    AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye

  • Published on 10/01/2026 at 18:40, 8 hours 52 minutes ago

    Monthly disclosure of the total number of shares and voting rights - September 2026

  • Published on 10/01/2026 at 18:40, 8 hours 52 minutes ago

    TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026

  • Published on 10/01/2026 at 18:07, 9 hours 26 minutes ago

    Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy